Osaic Holdings’s Titan Pharmaceuticals TTNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-10
| Closed | -$35 | – | 8184 |
|
|
2025
Q3 | $35 | Hold |
10
| – | – | ﹤0.01% | 7806 |
|
|
2025
Q2 | $40 | Sell |
10
-5
| -33% | -$21 | ﹤0.01% | 7627 |
|
|
2025
Q1 | $49 | Hold |
15
| – | – | ﹤0.01% | 7289 |
|
|
2024
Q4 | $47 | Buy |
15
+5
| +50% | +$20 | ﹤0.01% | 7296 |
|
|
2024
Q3 | $52 | Hold |
10
| – | – | ﹤0.01% | 7294 |
|
|
2024
Q2 | $54 | Hold |
10
| – | – | ﹤0.01% | 7298 |
|
|
2024
Q1 | $70 | Buy |
10
+8
| +400% | +$56 | ﹤0.01% | 7064 |
|
|
2023
Q4 | $13 | Sell |
2
-1
| -33% | -$7 | ﹤0.01% | 7221 |
|
|
2023
Q3 | $22 | Buy |
3
+1
| +50% | +$11 | ﹤0.01% | 7313 |
|
|
2023
Q2 | $23 | Hold |
2
| – | – | ﹤0.01% | 7369 |
|
|
2023
Q1 | $29 | Hold |
2
| – | – | ﹤0.01% | 7409 |
|
|
2022
Q4 | $18 | Buy |
2
+1
| +100% | +$19 | ﹤0.01% | 7132 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 7512 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7601 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 7507 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 7573 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 7314 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7129 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6950 |
|
|
2020
Q4 | $0 | Sell |
1
-1
| -50% | -$79 | ﹤0.01% | 6565 |
|
|
2020
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 6406 |
|
|
2020
Q2 | $0 | Buy |
2
+1
| +100% | +$172 | ﹤0.01% | 6332 |
|
|
2020
Q1 | $0 | Buy |
+1
| New | +$156 | ﹤0.01% | 6187 |
|
Other funds holding TTNP
CA
GWSA
CSC
DJSG
Osaic Holdings's TTNP Position: Q4 2025 in Review
Osaic Holdings sold out of Titan Pharmaceuticals (TTNP) in Q4 2025, closing a stake of 10 shares — an estimated $35 sold.
Osaic Holdings first reported a position in TTNP in Q1 2020 and held it in 23 quarters. The position peaked at $70 in Q1 2024. 4 funds tracked by Wall St. Rank hold TTNP as of Q4 2025.
- Osaic Holdings reported no remaining Titan Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Osaic Holdings sold 10 Titan Pharmaceuticals shares in Q4 2025, an estimated $35.
- Osaic Holdings first reported a position in Titan Pharmaceuticals in Q1 2020 and held it in 23 quarters.
- Osaic Holdings's Titan Pharmaceuticals position peaked at $70 in Q1 2024.
- 4 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q4 2025.
Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.